stephen silberstein, md, director, jefferson university headache center..: "targeted cgrp small molecule antagonists for acute migraine therapy.".
another new drug in the migraine pipeline is lasmiditan. it works the same way as triptans. but unlike the triptans, it doesn't constrict.